Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex

Completed · Phase 1

Conditions studied: Renal Impairment

In brief

This is a Phase 1 study to investigate the effects of Renal Impairment on the pharmacokinetics of Tenofovir exalidex

Key facts

Study ID

NCT03284164

Run by

ContraVir Pharmaceuticals, Inc.

People needed

16

Starts

2017-09-28

Expected to finish

2018-02-20

Last updated by the study team

2018-06-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age: 18 years of age and over
• Capable of giving written informed consent
• Capable of completing study requirements

You may not qualify if…

• Positive result for HIV, HBV, or HCV
• History or medical condition which could impact patient safety
• Current or past abuse of alcohol or drugs
• Participation in another clinical trial within the past 30 days

Where it is running

• Orlando Clinical Research Center — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.